Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study

R. G. Miller, Khema R Sharma, G. K. Pavlath, E. Gussoni, M. Mynhier, P. Yu, A. M. Lanctot, C. M. Greco, L. Steinman, H. M. Blau

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

We evaluated myoblast implantation in 10 boys with Duchenne muscular dystrophy (DMD) and absent dystrophin (age 5-10 years) who were implanted with 100 million myoblasts in the anterior tibial muscle of one leg and placebo in the other. Cyclosporine (5 mg/kg/day) was administered for 7 months. Pre- and postimplantation (after 1 and 6 months) muscle biopsies were analyzed. Force generation (tetanic tension and maximum voluntary contraction) was measured monthly in a double-blind design. There was increased force generation in both legs of all boys, probably due to cyclosporine. Using the polymerase chain reaction, evidence of myoblast survival and dystrophin mRNA expression was obtained in 3 patients after 1 month and in 1 patient after 6 months. These studies suggest a salutary effect of cyclosporine upon muscular force generation in Duchenne muscular dystrophy; however, myoblast implantation was not effective in replacing clinically significant amounts of dystrophin in DMD muscle.

Original languageEnglish
Pages (from-to)469-478
Number of pages10
JournalMuscle and Nerve
Volume20
Issue number4
DOIs
StatePublished - Apr 21 1997
Externally publishedYes

Fingerprint

San Francisco
Duchenne Muscular Dystrophy
Myoblasts
Dystrophin
Cyclosporine
Leg
Muscles
Skeletal Muscle
Placebos
Biopsy
Polymerase Chain Reaction
Messenger RNA

Keywords

  • cell transplantation
  • cyclosporine
  • Duchenne muscular dystrophy
  • gene therapy
  • myoblasts

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Myoblast implantation in Duchenne muscular dystrophy : The San Francisco study. / Miller, R. G.; Sharma, Khema R; Pavlath, G. K.; Gussoni, E.; Mynhier, M.; Yu, P.; Lanctot, A. M.; Greco, C. M.; Steinman, L.; Blau, H. M.

In: Muscle and Nerve, Vol. 20, No. 4, 21.04.1997, p. 469-478.

Research output: Contribution to journalArticle

Miller, RG, Sharma, KR, Pavlath, GK, Gussoni, E, Mynhier, M, Yu, P, Lanctot, AM, Greco, CM, Steinman, L & Blau, HM 1997, 'Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study', Muscle and Nerve, vol. 20, no. 4, pp. 469-478. https://doi.org/10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.0.CO;2-U
Miller, R. G. ; Sharma, Khema R ; Pavlath, G. K. ; Gussoni, E. ; Mynhier, M. ; Yu, P. ; Lanctot, A. M. ; Greco, C. M. ; Steinman, L. ; Blau, H. M. / Myoblast implantation in Duchenne muscular dystrophy : The San Francisco study. In: Muscle and Nerve. 1997 ; Vol. 20, No. 4. pp. 469-478.
@article{3d54b36552b743989ab4fa34b2146363,
title = "Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study",
abstract = "We evaluated myoblast implantation in 10 boys with Duchenne muscular dystrophy (DMD) and absent dystrophin (age 5-10 years) who were implanted with 100 million myoblasts in the anterior tibial muscle of one leg and placebo in the other. Cyclosporine (5 mg/kg/day) was administered for 7 months. Pre- and postimplantation (after 1 and 6 months) muscle biopsies were analyzed. Force generation (tetanic tension and maximum voluntary contraction) was measured monthly in a double-blind design. There was increased force generation in both legs of all boys, probably due to cyclosporine. Using the polymerase chain reaction, evidence of myoblast survival and dystrophin mRNA expression was obtained in 3 patients after 1 month and in 1 patient after 6 months. These studies suggest a salutary effect of cyclosporine upon muscular force generation in Duchenne muscular dystrophy; however, myoblast implantation was not effective in replacing clinically significant amounts of dystrophin in DMD muscle.",
keywords = "cell transplantation, cyclosporine, Duchenne muscular dystrophy, gene therapy, myoblasts",
author = "Miller, {R. G.} and Sharma, {Khema R} and Pavlath, {G. K.} and E. Gussoni and M. Mynhier and P. Yu and Lanctot, {A. M.} and Greco, {C. M.} and L. Steinman and Blau, {H. M.}",
year = "1997",
month = "4",
day = "21",
doi = "10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.0.CO;2-U",
language = "English",
volume = "20",
pages = "469--478",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Myoblast implantation in Duchenne muscular dystrophy

T2 - The San Francisco study

AU - Miller, R. G.

AU - Sharma, Khema R

AU - Pavlath, G. K.

AU - Gussoni, E.

AU - Mynhier, M.

AU - Yu, P.

AU - Lanctot, A. M.

AU - Greco, C. M.

AU - Steinman, L.

AU - Blau, H. M.

PY - 1997/4/21

Y1 - 1997/4/21

N2 - We evaluated myoblast implantation in 10 boys with Duchenne muscular dystrophy (DMD) and absent dystrophin (age 5-10 years) who were implanted with 100 million myoblasts in the anterior tibial muscle of one leg and placebo in the other. Cyclosporine (5 mg/kg/day) was administered for 7 months. Pre- and postimplantation (after 1 and 6 months) muscle biopsies were analyzed. Force generation (tetanic tension and maximum voluntary contraction) was measured monthly in a double-blind design. There was increased force generation in both legs of all boys, probably due to cyclosporine. Using the polymerase chain reaction, evidence of myoblast survival and dystrophin mRNA expression was obtained in 3 patients after 1 month and in 1 patient after 6 months. These studies suggest a salutary effect of cyclosporine upon muscular force generation in Duchenne muscular dystrophy; however, myoblast implantation was not effective in replacing clinically significant amounts of dystrophin in DMD muscle.

AB - We evaluated myoblast implantation in 10 boys with Duchenne muscular dystrophy (DMD) and absent dystrophin (age 5-10 years) who were implanted with 100 million myoblasts in the anterior tibial muscle of one leg and placebo in the other. Cyclosporine (5 mg/kg/day) was administered for 7 months. Pre- and postimplantation (after 1 and 6 months) muscle biopsies were analyzed. Force generation (tetanic tension and maximum voluntary contraction) was measured monthly in a double-blind design. There was increased force generation in both legs of all boys, probably due to cyclosporine. Using the polymerase chain reaction, evidence of myoblast survival and dystrophin mRNA expression was obtained in 3 patients after 1 month and in 1 patient after 6 months. These studies suggest a salutary effect of cyclosporine upon muscular force generation in Duchenne muscular dystrophy; however, myoblast implantation was not effective in replacing clinically significant amounts of dystrophin in DMD muscle.

KW - cell transplantation

KW - cyclosporine

KW - Duchenne muscular dystrophy

KW - gene therapy

KW - myoblasts

UR - http://www.scopus.com/inward/record.url?scp=8244228688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8244228688&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.0.CO;2-U

DO - 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.0.CO;2-U

M3 - Article

C2 - 9121505

AN - SCOPUS:8244228688

VL - 20

SP - 469

EP - 478

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 4

ER -